R3 Stem Cell Publishes Comprehensive Clinical Review of Intranasal Stem Cell Therapy in Frontiers in Aging Neuroscience

R3 Stem Cell, a top regenerative medicine company, announced the publication of a systematic review by its Research ...

R3 Stem Cell Receives Trademark Registration for ‘Regenerative Trifecta’ Protocol Brand Across Its Global Clinic Network

R3 Stem Cell's trademark for "Regenerative Trifecta" formalizes the brand identity of a clinical protocol used across ...
Tallahassee Democrat

R3 Stem Cell Publishes Paper on Regenerative Power and Biomechanics of Wharton’s Jelly in World Journal of Stem Cells

Comprehensive review led by R3’s Department of Research consolidates emerging evidence on Wharton’s jelly function, biomechanics and superior clinical results. Our review brings together the clinical, ...
KXAN

R3 Stem Cell's New Alliance Program Brings Regenerative Procedures to Practices and New Revenue

R3 Stem Cell announced the new and improved R3 Alliance Program. R3 generates regenerative cases and books them with Alliance members on a revenue share basis. Our process involves bringing patients ...
Stevens Point Journal

R3 Stem Cell Named ‘Regenerative Medicine Company of the Year – Global’ by International Elite 100

R3 Stem Cell has been honored with the prestigious Regenerative Medicine Company of the Year Global award by International Elite 100. It’s an honor to have received this award 5 years in a row. Thank ...